These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 6146149)

  • 1. [Effect of DN-1417 (TRH analog) on schizophrenic patients].
    Mizuki Y; Takada Y; Tsujimaru H; Takii O; Nishijima H
    Seishin Shinkeigaku Zasshi; 1983; 85(11):808-12. PubMed ID: 6146149
    [No Abstract]   [Full Text] [Related]  

  • 2. A treatment trial with an analog of thyrotropin-releasing hormone (DN-1417) in schizophrenia.
    Mizuki Y; Nishikori S; Kajimura N; Imaizumi J; Yamada M; Inanaga K
    Biol Psychiatry; 1985 Sep; 20(9):1030-5. PubMed ID: 2862926
    [No Abstract]   [Full Text] [Related]  

  • 3. A treatment trial with an analog of thyrotropin-releasing hormone (DN-1417) and des-tyrosine-gamma-endorphin in schizophrenia.
    Mizuki Y; Ushijima I; Yamada M; Tanaka M; Inanaga K
    Int Clin Psychopharmacol; 1986 Oct; 1(4):303-13. PubMed ID: 2881964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of the TRH analog DN-1417 on the appearance of frontal midline theta activity (Fm0)].
    Nakamura J; Mukasa H; Hashimoto M; Inanaga K
    Yakubutsu Seishin Kodo; 1987 Jun; 7(2):321-6. PubMed ID: 2891228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyrotropin-releasing hormone in schizophrenia.
    Davis KL; Hossister LE; Berger PA
    Am J Psychiatry; 1975 Sep; 132(9):951-3. PubMed ID: 808141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of DN-1417 on ataxia in Rolling mouse Nagoya and Staggerer mouse in comparison with the effect of TRH].
    Matsui K; Mano Y; Ando K
    Yakubutsu Seishin Kodo; 1986 Jun; 6(2):281-3. PubMed ID: 3096012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of amyotrophic lateral sclerosis with the TRH analog DN-1417.
    Hawley RJ; Kratz R; Goodman RR; McCutchen CB; Sirdofsky M; Hanson PA
    Neurology; 1987 Apr; 37(4):715-7. PubMed ID: 3104820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anticonvulsant effect of a novel TRH analog (DN-1417) on amygdaloid kindled seizure II; comparison with TRH tytrate].
    Morimoto K; Moriwake T; Sato M; Otsuki S
    No To Shinkei; 1983 May; 35(5):501-4. PubMed ID: 6414496
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anticonvulsant effect of a novel TRH analog (DN-1417) on amygdaloid kindled seizure].
    Morimoto K; Moriwake T; Akiyama T; Sato M; Otsuki S
    No To Shinkei; 1983 Feb; 35(2):189-95. PubMed ID: 6405763
    [No Abstract]   [Full Text] [Related]  

  • 10. Prolactin and somatotropin responses to TRH in schizophrenic patients.
    Posmurová M; Hainer V; Marek J; Filip V; Srámková J
    Act Nerv Super (Praha); 1979 Oct; 21(3):171-3. PubMed ID: 117668
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of TRH and its analog DN-1417 on anoxia-induced amnesia in mice].
    Yamazaki N; Shintani M; Saji Y; Nagawa Y
    Yakubutsu Seishin Kodo; 1985 May; 5(1):1-9. PubMed ID: 2996254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effectiveness of TRH analog in a case of early infantile epileptic encephalopathy].
    Ishii M; Tamai K; Sugita K; Tanabe Y
    No To Hattatsu; 1990 Sep; 22(5):507-11. PubMed ID: 2121173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of five beta-LPH-neuropeptides and DN-1417, a derivative of TRH, on grip test performance in rats: possible neuroleptic action.
    Tanaka M; Hoaki Y; Mizuki Y; Inanaga K
    Kurume Med J; 1982; 29(2):69-74. PubMed ID: 6132021
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of a thyrotropin releasing hormone analog in a patient with myoclonus epilepsy.
    Inanaga K; Inoue Y
    Kurume Med J; 1981; 28(3):201-10. PubMed ID: 6806526
    [No Abstract]   [Full Text] [Related]  

  • 15. Synthetic thyroid releasing hormone (TRH) administered orally to chronic schizophrenic patients.
    Clark ML; Paredes A; Costiloe JP; Wood F
    Psychopharmacol Commun; 1975; 1(2):191-200. PubMed ID: 817373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The EEG effects of thyreotropin releasing hormone in healthy subjects and chronic schizophrenics.
    Hynek K; Filip V
    Act Nerv Super (Praha); 1979 Oct; 21(3):173-4. PubMed ID: 117669
    [No Abstract]   [Full Text] [Related]  

  • 17. Behavioral effects of L-dopa and thyrotropin-releasing hormone in schizophrenic patients: a preliminary report.
    Inanaga K; Ohshima M; Nagata T; Yamauchi I
    Folia Psychiatr Neurol Jpn; 1975; 29(3):197-205. PubMed ID: 814071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anticonvulsant effects of TRH analog. 3. Prophylactive effects of DN-1417 on kindling model].
    Morimoto K; Moriwake T; Sato M; Otsuki S
    No To Shinkei; 1983 Aug; 35(8):787-93. PubMed ID: 6416278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal delivery of a thyrotropin-releasing hormone analog attenuates seizures in the amygdala-kindled rat.
    Veronesi MC; Kubek DJ; Kubek MJ
    Epilepsia; 2007 Dec; 48(12):2280-6. PubMed ID: 17651414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary studies on the effects of a TRH analog, MK-771, in an animal model of Alzheimer's disease.
    Horita A; Carino MA; Lai H
    Proc West Pharmacol Soc; 1987; 30():57-8. PubMed ID: 3114755
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.